Stay ahead in medical device compliance with in-depth training on the FDA’s classification of hyperoxia monitoring devices adjunct to pulse oximetry as Class II with special controls. This course focuses on actionable compliance strategies, details the required clinical, usability, and safety testing, and clarifies documentation and labeling obligations. Learn what the new regulatory landscape means for manufacturers, sponsors, and other stakeholders—and how to ensure uninterrupted market access under the latest FDA rule.
In this course you will learn the following:
* Understand the FDA’s rationale for classifying the device as class II with special controls.
* Identify the specific special controls and general controls applicable to this device type.
* Implement the required testing, labeling, and documentation to ensure compliance.
* Recognize the regulatory pathways for marketing this device and the implications for future devices.
* Appreciate the legal and financial consequences of failing to comply with the final rule.
